Ledger.Open graph →
SEC Form D · filed August 24, 2016

Moderna Therapeutics, Inc

Offering
$600.0M
Sold
$451.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Peter Hutt · Cambridge, MADirectorJohn Mendlein · Cambridge, MADirectorJames R. Kasinger · Cambridge, MAExecElizabeth Nabel · Cambridge, MADirectorStephen Hoge · Cambridge, MAExecHenri Termeer · Cambridge, MADirectorNoubar Afeyan · Cambridge, MADirectorLee Babiss · Cambridge, MADirectorLorence Kim · Cambridge, MAExecStephane Bancel · Waltham, MAExec · DirectorRobert Langer · Bedford, MADirectorLorence Kim · Cambridge, MAExecStephane Bancel · Cambridge, MAExec · DirectorRobert Langer · PITTSBURGH, PADirectorPeter Hutt · Cambridge, MEDirectorJohn Mendlein · San Diego, CADirectorJames R. Kasinger · Cambridge, MAExecElizabeth Nabel · Cambridge, MADirectorStephen Hoge · Cambridge, MAExecHenri Termeer · Cambridge, MADirectorNoubar Afeyan · Cambridge, MADirectorLee Babiss · Research Triangle Park, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗